Laboratory tests for protein C deficiency

American Journal of Hematology

Volumn 85, Issue 6, 2010, Pages 440-442

  Khor, Bernard ^a   Van Cott, Elizabeth M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ARGATROBAN; FRESH FROZEN PLASMA; HIRUDIN; HIRULOG; PROTEIN C;

ANTICOAGULATION; ARTERY THROMBOSIS; BLOOD CLOTTING TIME; BRAIN ISCHEMIA; DIAGNOSTIC VALUE; DISSEMINATED INTRAVASCULAR CLOTTING; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; LABORATORY TEST; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; REVIEW; SCREENING TEST; SUBSTITUTION THERAPY;

ALGORITHMS; ARTIFACTS; BLOOD COAGULATION TESTS; BLOOD PROTEINS; CHROMOGENIC COMPOUNDS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HUMANS; IMMUNOASSAY; PARTIAL THROMBOPLASTIN TIME; PROTEIN C; PROTEIN C DEFICIENCY; PROTHROMBIN TIME; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; THROMBOPHILIA;

EID: 77953077082     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21679     Document Type: Review

References (33)

1. Miletich J, Sherman L, Broze G Jr. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 1987;317:991-996. (Pubitemid 17147955)
2. Tait RC, Walker ID, Reitsma PH, et al. Prevalence of protein C deficiency in the healthy population. Thromb Haemost 1995;73:87-93.
3. van der Meer FJ, Koster T, Vandenbroucke JP, et al. The Leiden Thrombophilia Study (LETS). Thromb Haemost 1997;78:631-635.
4. Melissari E, Monte G, Lindo VS, et al. Congenital thrombophilia among patients with venous thromboembolism. Blood Coagul Fibrinolysis 1992;3: 749-758. (Pubitemid 23026819)
5. Vossen CY, Conard J, Fontcuberta J, et al. Familial thrombophilia and lifetime risk of venous thrombosis. J Thromb Haemost 2004;2:1526-1532.
6. Mahmoodi BK, Brouwer JL, Veeger NJ, van der Meer J. Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: Results from a large family cohort study. Circulation 2008;118:1659-1667.
7. Rahemtullah A, Van Cott EM. Hypercoagulation testing in ischemic stroke. Arch Pathol Lab Med 2007;131:890-901.
8. Finazzi G, Barbui T. Different incidence of venous thrombosis in patients with inherited deficiencies of antithrombin III, protein C and protein S. Thromb Haemost 1994;71:15-18. (Pubitemid 24023781)
9. Allaart CF, Poort SR, Rosendaal FR, et al. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 1993;341:134-138.
10. Tripodi A, Franchi F, Krachmalnicoff A, Mannucci PM. Asymptomatic homozygous protein C deficiency. Acta Haematol 1990;83:152-155.
11. Reitsma PH. Protein C deficiency: From gene defects to disease. Thromb Haemost 1997;78:344-350.
12. Reitsma PH, Bernardi F, Doig RG, et al. Protein C deficiency: A database of mutations, 1995 update. On behalf of the subcommittee on plasma coagulation inhibitors of the scientific and standardization committee of the ISTH. Thromb Haemost 1995;73:876-889.
13. Kottke-Marchant K, Comp P. Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin, and endothelial cell protein C receptor. Arch Pathol Lab Med 2002;126:1337-1348. (Pubitemid 36237284)
14. Cooper PC, Cooper SM, Goodfellow KJ, et al. Evaluation of a new venom-based clotting assay of protein C. Int J Lab Hematol 2008;30:437-443.
15. Walenga JM, Fasanella AR, Iqbal O, et al. Coagulation laboratory testing in patients treated with argatroban. Semin Thromb Hemost 1999;25(Suppl 1): 61-66. (Pubitemid 29230567)
16. Manufacturer's package insert for Clot C, Precision Biologic, Dartmouth, Nova Scotia; Canada 2007.
17. Ireland H, Bayston T, Thompson E, et al. Apparent heterozygous type II protein C deficiency caused by the factor V 506 Arg to Gln mutation. Thromb Haemost 1995;73:731-732.
18. Vasse M, Borg JY, Monconduit M. Protein C: Rouen, a new hereditary protein C abnormality with low anticoagulant but normal amidolytic activities. Thromb Res 1989;56:387-398. (Pubitemid 20003592)
19. Wojcik EG, Simioni P, d Berg M, et al. Mutations which introduce free cysteine residues in the Gla-domain of vitamin K dependent proteins result in the formation of complexes with alpha 1-microglobulin. Thromb Haemost 1996; 75:70-75.
20. Meijer P, Kluft C, Haverkate F, De Maat MP. The long-term within- and between-laboratory variability for assay of antithrombin, and proteins C and S: Results derived from the external quality assessment program for thrombophilia screening of the ECAT Foundation. J Thromb Haemost 2003;1:748-753.
21. Mitchell CA, Rowell JA, Hau L, et al. A fatal thrombotic disorder associated with an acquired inhibitor of protein C. N Engl J Med 1987;317:1638-1642. (Pubitemid 18010469)
22. Malm J, Laurell M, Dahlback B. Changes in the plasma levels of vitamin K-dependent proteins C and S and of C4b-binding protein during pregnancy and oral contraception. Br J Haematol 1988;68:437-443.
23. Clark P, Brennand J, Conkie JA, et al. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998;79: 1166-1170. (Pubitemid 28297166)
24. Brenner B. Haemostatic changes in pregnancy. Thromb Res 2004;114:409-414.
25. Kjellberg U, Andersson NE, Rosen S, et al. APC resistance and other haemostatic variables during pregnancy and puerperium. Thromb Haemost 1999;81: 527-531.
26. Rodeghiero F, Tosetto A. The VITA Project: Population-based distributions of protein C, antithrombin III, heparin-cofactor II and plasminogen-- relationship with physiological variables and establishment of reference ranges. Thromb Haemost 1996;76:226-233.
27. Henkens CM, Bom VJ, Van Der Schaaf W, et al. Plasma levels of protein S, protein C, and factor X: Effects of sex, hormonal state and age. Thromb Haemost 1995;74:1271-1275.
28. Dolan G, Neal K, Cooper P, et al. Protein C, antithrombin III and plasminogen: Effect of age, sex and blood group. Br J Haematol 1994;86:798-803.
29. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood 1987;70:165-172.
30. Andrew M, Vegh P, Johnston M, et al. Maturation of the hemostatic system during childhood. Blood 1992;80:1998-2005.
31. Monagle P, Barnes C, Ignjatovic V, et al. Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost 2006;95:362-372.
32. Laposata M, Van Cott EM. How to work up hypercoagulability. CAP Today 2000;14:24-26.
33. Toh CH, Samis J, Downey C, et al. Biphasic transmittance waveform in the APTT coagulation assay is due to the formation of a Ca(++)-dependent complex of C-reactive protein with very-low-density lipoprotein and is a novel marker of impending disseminated intravascular coagulation. Blood 2002;100: 2522-2529.